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EMERGENCY PORTACAVAL SHUNTS IN VARICEAL
HEMORRAGE: A CRITIQUE OF CRITICS
ABSTRACT
Orloff, M. J., Orloff, M. S., Rabotti, M. and Girard, B. (1992) Is portal-systemic shunt
worthwhile in Child’s Class C cirrhosis. Annals ofSurgery, 216, 256-268.
A prospective evaluation was conducted of 94 unselected patients ("all comers") with
biopsy-proven Child’s class C cirrhosis (93% alcoholic) and endoscopically proven
acutely bleeding esophageal varices who underwent emergency portacaval shunt (EPCS)
(85% side-to-side, 15% end-to-side) within 8 hours of initial contact (mean, 6.1 hours)
during the past 12 years. Follow-up has been 100% and includes all patients for at least
I year, and 61 patients (65%) for 5 to 12 years. Incidence of serious risk factors on initial
contact was: ascites, 97%; jaundice, 86%; portal-systemic encephalopathy including past
history, 71%; severe muscle wasting, 96%; alcohol ingestion within 7 days, 66%; delirium
tremens, 16%; serum albumin, < 2.5 g/dL 76%; indocyanine green dye retention > 50%
in 45 minutes, 66%; serum glutamic-oxaloacetic transaminase > 100 units/L, 60%;
hyperdynamic cardiac output > 6 L/minute, 98%. Mean Child’s point score was 13.7 out
of a maximum of 15. EPCS reduced mean corrected free portal pressure from 286 to 23
mm saline, and permanently controlled variceal bleeding in every patient. Of the 94
patients, 74 (80%) left the hospital alive and 68 (72%) survived I year. Five year actuarial
survival rate is 64%. Hepatic failure was the main cause of death during initial
hospitalization as well as during follow-up, when it was related to continued alcoholism.
Portal-systemic encephalopathy, which was present on initial contact in 55% of patients,
occurred at some time during follow-up in 18.7%, but was recurrent and required dietary
protein restriction in only 9%, all ofwhom had resumed alcoholism. The low incidence of
portal-systemic encephalopathy was attributable to the lifelong program of follow-up
with regular dietary counseling and continued emphasis on both protein restriction to
60 g/day and abstinence from alcohol. Abstinence was sustained in 69%, liver function
improved in 82%, general health was judged excellent or good in 73%, and Child’s risk
class converted to class B in 73% and class A in 21%. Excluding retirees because of age,
42% were gainfully employed or engaged in full-time house-keeping.. Long-term shunt
patency was documented in 100% of survivors by yearly angiography or Doppler
ultrasonography. It is concluded that EPCS within 8 hours of initial contact permanently
controls variceai hemorrhage and results in prolonged survival and a life of acceptable
quality in many alcoholic cirrhotic patients in Child’s class C. The improvement in our
results compared with the previously reported results of all forms of treatment is attribu-
table to rapid diagnosis, prompt operation, an organized system of care, and rigorous
lifelong follow-up. The widespread pessimism about these patients is not justified, and the
suggestion that liver transplantation offers the only or best hope is unwarranted,
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PAPER DISCUSSION
Don’t throw out the baby with the bath water Proverb
(first citation) Keppler 1610
I have long enjoyed the policy of the American Journal
of Surgery which appends comments by the audience
and the responses of the speaker about papers pres-
ented at their annual meeting. Often these discussionsHPB INTERNATIONAL 63
are as informative as the articles themselves. The dis-
cussion of Marshall Orloff’s article on emergency
portacaval shunts (EPCS) in patients with Child’s
C cirrhosis is a case in point1. Dr. Bernard Langer of
Toronto, a highly respected surgeon, commented that
Orloff’s article is "...remarkable for its low operat-
ive mortality and its long term survival...for the fact
that... 94% ofthe Child’s C patients reverted to Child’s
A or B, and that these figures.., are at odds with almost
anything else that has been published in the literature".
Dr. Langer seems incredulous about these data and has
difficulty in accepting them at face value. However, Dr.
Langer, whom I have known for almost 30 years, is a
true gentleman, and, inmy opinion, his comments are as
close as he can come to cry, "Fraud". Indeed, he didn’t.
Instead, he suggested other explanations for these egre-
gious data. Could the delay of 24 or 48 hours be resr
ponsible for the difference in Orloff’s results and those
of others? Is it possible that Orloff’s patients are heal-
thier than true childs Class C patients, due to differen-
ces in the Child-Turcotte and Child-Turcotte-Campbell
classifications? He mutes his disbelief in concluding
that, "I am not convinced that surgery should be first-
line therapy for every patient who is bleeding from
varices". Others, who are not so gentle, who do not read
so carefully, and/or who are irritated by Orloff’s pro-
vocative style, seem to dismiss his results as exagger-
ations or worse, and to close their minds to his explana-
tions of how he achieved such astounding results.
For over a quarter of a century Orloff has been the
standard bearer for EPCS and he has madeUCSD the
world’s capital ofemrgency shunts. His message is loud,
clear and strident. In a long series of articles he has
explained why he believes that EPCS is the treatment
ofchoice for bleeding varices and in the process contra-
dicts the cumulative results of dozens of experienced
investigators. In the latest article in this series, which
can be considered the scripture on which this sermon is
based, he and his associates present the observations
that are so difficult for so many to accept. What are
these astounding results? The article describes their
findings in "...94 consecutive, unselected" patients with
Child’s Class C cirrhosis inwhom this difficult procedure
was successfully accomplished in all within 8 hours of
admission to the hospital (mean 6.1 hours) and inwhom
the procedure stopped the bleeding immediately and
"...permanenty controlled the hemorrhage in every pa-
tient, none ofwhom was lost tofollow-up before 5 years".
Furthermore, 80o//o left the hospital alive, 64//0 survived
for 5 years, abstinance was sustained in 69//o ofthis largely
alcoholic group, in only 9o//0 portal-systemic encepha-
lopathy (PSE) "...was recurrent and required dietary
protein restriction...", long term shunt patency was
documented in 100% by yearly angiography or Dop-
pler ultrasonography. These are outrageous claims,
outrageously stated. The single most impressive state-
ment is that Child’s class C "...reverted to Class B in
73% and to Class A in 21%". In vintage Orloffian style
he ends with the zinger, "...there is no justificationfor
the widespread pessimism and fatalistic attitude about
patients with class C cirrhosis who bleed from varices".
That is pouring salt into the wound! To my knowledge
no one has reported as high rates ofsuccessful perform-
ance ofEPCS, offollow-up, ofabstension from alcohol,
of survival, of shunt patency, of improvement in hepa-
tic status or as low a rate of postshunt PSE.
Why are these results so difficult to accept? First,
because they are so much better than any other report-
ed data. Second, I believe, because they are presented in
such a direct, cheerful, ingenuous manner that the reader
is made to feel inadequate, demeaned and defensive.
His confrontational style, which is probably subcon-
scious, attracts attention. For one to state emphatically
that one’s work is superior to all others’ rarely elicits
a warm, friendly response. However, we must take care
not to discard the substance because of the style.
Let’s examine the individual claims: 94 consecutive
anythings is pretty good, but 94 consecutive EPCS in
child’s class C patients represents a record that may
never be broken. The absence of a single shunt occlu-
sion is another world’s record. Only 9% with chronic
post-shunt PSE is truly noteworthy. I suspect that
rigorous examination by experienced encephalopatho-
logists might well identify additional cases, but I doubt
many more. The detection of subtle PSE is a subjective
art form2. Besides, the patients all had been on mild
dietary protein restriction (60 g per pay). Actually, the
portal decompression, which prevents hemorrhage from
varices, which is one of the most common causes of
PSE, may itself have diminished the frequency of PSE.
Let’s put the post-shunt PSE in this investigation
into proper perspective. More than half of these 94
patients had had PSE when they were first examined,
while they were actively bleeding. An additional 16%
gave a history of previous PSE; thus, 71% of these
patients had apparently exhibited PSE prior to EPCS.
Patients who develop PSE are unusually susceptible to
subsequent episodes3. In the post-operative period 22
patients (23%) experienced PSE, usually in the pres-
ence of hypokalemic, Metabolic alkalosis, a known
precipitant ofPSE*. AfterEPCS 9 patients experienced
a single episode of PSE. An additional 9 patients (7%)
developed recurrent PSE that required further reduc-
tion of protein intake and the administration of64 HPB INTERNATIONAL
lactulose. All 18 patients had resumed heavy alcohol
intake despite repeated emphasis during follow-up
about abstinence from alcohol and protein restriction.
These associations demonstrate the multiplicity of fac-
tors that contribute to post-shunt PSE and emphasizes
two of the cornerstones of Orloff’s follow-up ther-
apy-abstinence and protein restriction.
In an earlier controlled comparison of PSE in
shunted and unshunted cirrhotic patients with esopha-
geal varices the results were not dissimilar 5. Recurrent
PSE occurred in 20% of the shunted patients and in
only 3% of the unshunted patients. The most common
precipitant of PSE in the shunted patients was dietary
protein and in unshunted patients it was gastrointes-
tinal bleeding. Thus the presence ofa patent PCS per se
reduces the risk ofPSE in shunted patients by reducing
the risk of homorrhage.
I have had the opportunity to assess the validity of
some aspects of Orloff’s claims by interrogating phys-
icians, surgeons, house officers and GI fellows at
UCSD. I have not found a single instance in which any
patients have been knowingly excluded from having
EPCS. When I informed Orloff of this surveillance he
volunteered to assist my agents. Probably, some pa-
tientswho were thought to be especially poor operative
risks were diverted to other hospitals, but it is not
possible to estimate the extent of this referral bias.
Furthermore, as a member of the External Advisory
Committee of the NIH sponsored San Diego EPCS vs
Sclerotherapy randomized clinical trial, I have had the
opportunity to examine the records of some of these
patients. I have been unable to uncover a single episode
of deception. I found the records from this investigation
to be carefully documented, and amazingly complete.
To me the reversal of Child’s C patients to A or B in
the large majority ofpatients is the single most remark-
able observation. This effect may largely reflect improve-
ment in ascites, which can reduce Child’s score by 1 or
2 points and may result in improved nutrition. Similar
claims have been made for the effect ofperitoneavenous
shunts6. The second most surprising claim to me, is the
statement that "...no patient with bleeding varices has
ever refused EPCS at UCSD University Hospital".
I have confronted Orloff directly about this statement:
"Would you dare refuse if I told you that the oper-
a’tion was essential to your wellbeing?" he responded,
loudly, pushing his pugnacious jaw close to mine.
"No, sir," I replied.
Orloffbelieves that the key principies responsible for
his success are (a) rapid diagnosis, (b) prompt surgery,
(c) an organized system of care and (d) lifelong follow-
up. I add (e) an excellent, experienced surgeon.
Postoperatively Orloff’s patients are followed close-
ly and each complication is promptly and vigorously
treated Good-nutrit. Nutrition and abstinance are
stressed. In my opinion the key to EPCS is the prompt
performance ofthe shunt, which saves at aminimum 12
to 36 hours of potential clinical deterioration. An early
emergency shunt diminishes the amount of blood lost
and blood replacement. Continued bleeding induces
vascular instability, a catabolic state and a decrease in
oxygen delivery to all the vital organs. It can cause
shock with severe renal and central nervous system
injury. Encephalopathy, too, is a component of the
child’s score and prompt cessation of bleeding dimin-
ishes the increase in hyperammonemia and can thus
reduce Child’s score by 1 or 2 points. Each blood
transfusion increases the hemolyticcomponent and the
opportunity for electrolyte abnormalities, under-or
overhydration, azotemia, transfusion mismatches and
the transmission of infectious diseases.
The shunt procedure itself eliminates the portal
hypertension and improves the hepatic, splanchnic and
systemic circulations. In addition, it decreases the
amount of ascites which may improve systemic and renal
hemodynamics and decrease the risks of spontaneous
bacterial peritonitis and the hepatorenal syndrome.
Shunts performed within a few hours of the onset
hemorrhage appear to be safer than those performed
a few days or weeks later because the patient at that
time is in as good health as he or she will ever again
achieve and can tolerate the effects of trauma, anes-
thesia, blood loss, etc., better. Timing is very important.
Child’s score may not be the same 3 hours after admis-
sion as it is 24 hours later. The higher serum bilirubin
concentration may easily add 1 or 2 points to the
Child’s score, changing a patient from class A to B or
BtoC.
Some of these concepts have been confirmed in the
preliminary report of a RCT in which EPCS has been
compared with emergency medical therapy (vasopres-
sin and/or esophageal balloon tamponade) followed by
elective PCS8. The 45 patients in the two groups were
similar in demographic and clinical features and to the
large series under discussion here. The outcome was
greatly improved by EPCS, after which all patients
stopped bleeding, compared to < 50% in the medical-
elective PCS group. The mean reduction in transfusion
requirements was 10 units, and survival was signifi-
cantly better at 30 days, 1 year and 5 years. Further-
more, the mean cost ofEPCS was no greater and after
30 days became progressively less. This important
study, which has so far been reported only in abstract
form, has now been submitted for publication.HPB INTERNATIONAL 65
Clearly it is essential to have an organized, experi-
enced team in place. One needs an energetic endo-
scopist, an aggressive surgeon; a capable anesthesio-
logist and the rest of the supporting cast to undertake
prompt diagnostic procedures, perform major surgery
quickly, to provide nutritional support and to carry the
patient through the post-operative period and a long
term follow-up.
Despite all this praise, Orloffis not perfect. He makes
the point that he is using the Child-Turcotte-Campbell
system of grading the severity of cirrhosis 7, but he is
not. In the Campbell modification it is necessary to
determine whether the ascites is "easily controlled" or
"difficult to control", decisions that require multiple
observations. In Orloff’s series ascites is graded on its
preserved absence and volume immediately after a dis-
cussion. Furthermore, there are better methods of
treating active bleeding than by infusing vasopressin.
One aspect of these data must be taken into serious
consideration, i.e. "The Wizard Phenomenon". A wiz-
ard is defined as "one endowed with exceptional
skill...and able to achieve something held to be im-
possible’’9. Orloff’s reported feats with EPCS surgery
easily satisfy this definition. One must worry whether
subsequent surgeons can equal Orloff’s achievements,
but this lis the way of the world. In all fields ofhuman
endeavor progress is made by incremental break-
throughs. On October 18, 1968, for example Bob Be-
amon made a prodigious longjump at the Olympics is
Mexico City (8.90 m), almost 22 inches, longer than the
existing world record, which had changed less than
8 inches in 33 years. In 1991, this new record, too, was
broken o. Starzl et al., performed the first liver trans-
plant in a human in 1963 a unique occurrence thought
then to be of little practical value, and now, thirty years
later, this procedure is performed as standard therapy
at hundreds of hospitals. EPCS has been performed by
many surgeons formany years, perhaps, not so success-
fully as Orloff, but I predict that using a different time
frame, surgeons will be able to perform this procedure
as rapidly and effectively as the Wizard of San Diego.
After considering all these data I think that EPCS
may be the one true treatment of actively bleeding
varices and that Orloff is its prophet.
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